Skip to main content
Top
Published in: Breast Cancer 1/2019

01-01-2019 | Original Article

Quantitative assessment and risk factors for nipple–areolar complex malposition after nipple-sparing mastectomy

Authors: Takaya Makiguchi, Hideharu Nakamura, Takaaki Fujii, Satoshi Yokoo

Published in: Breast Cancer | Issue 1/2019

Login to get access

Abstract

Purpose

Nipple sparing mastectomy (NSM) for breast cancer preserves the nipple–areola complex (NAC) and has limited the extent of the scar, giving good cosmetic results. However, NAC malposition may occur. The aim of this study is to evaluate NAC malposition after NSM and to determine factors associated with malposition in two-stage reconstruction.

Methods

The subjects were 46 patients who underwent unilateral NSM, without contralateral mastopexy or reduction surgery, in two-stage reconstruction using an expander with implant or flap replacement. Vertical and horizontal NAC malposition and predictors of malposition were evaluated before and more than 1 year after reconstruction surgery.

Results

The total amount of saline injected into the expander and aging were significant predictors of increased superior malposition of NAC before and more than 1 year after reconstruction or implant surgery. In contrast, the amount of saline injected into the expander until 2 weeks after expander insertion was a significant predictor of decreased superior NAC malposition. BMI was also a statistically significant predictor of decreased superior NAC malposition, but this result was likely to have been due to the measurement method. Autologous reconstruction was a significant negative predictor of superior malposition at more than 1 year after surgery. Superior NAC malposition resulting from full expansion of the expander improved by a mean vertical angle of 4.5° after autologous reconstruction, but hardly improved after implant use. In autologous reconstruction, NAC tended to move slightly to the lateral side after autologous reconstruction, compared to implant use.

Conclusions

Until 2 weeks after expander insertion, as much saline as possible should be injected to prevent superior NAC malposition. At full expansion, superior malposition of vertical angle > 4.5° may require repositioning surgery.
Literature
1.
go back to reference Donovan CA, Harit AP, Chung A, Bao J, Giuliano AE, Amersi F. Oncological and surgical outcomes after nipple-sparing mastectomy: do incisions matter? Ann Surg Oncol. 2016;23:3226–31.CrossRefPubMed Donovan CA, Harit AP, Chung A, Bao J, Giuliano AE, Amersi F. Oncological and surgical outcomes after nipple-sparing mastectomy: do incisions matter? Ann Surg Oncol. 2016;23:3226–31.CrossRefPubMed
2.
go back to reference Moo TA, Pinchinat T, Mays S, Landers A, Christos P, Alabdulkareem H, Tousimis E, Swistel A, Simmons R. Oncologic outcomes after nipple-sparing mastectomy. Ann Surg Oncol. 2016;23:3221–5.CrossRefPubMed Moo TA, Pinchinat T, Mays S, Landers A, Christos P, Alabdulkareem H, Tousimis E, Swistel A, Simmons R. Oncologic outcomes after nipple-sparing mastectomy. Ann Surg Oncol. 2016;23:3221–5.CrossRefPubMed
3.
go back to reference Benediktsson KP, Perbeck L. Survival in breast cancer after nipple-sparing subcutaneous mastectomy and immediate reconstruction with implants: a prospective trial with 13 years median follow-up in 216 patients. Eur J Surg Oncol. 2008;34:143–8.CrossRefPubMed Benediktsson KP, Perbeck L. Survival in breast cancer after nipple-sparing subcutaneous mastectomy and immediate reconstruction with implants: a prospective trial with 13 years median follow-up in 216 patients. Eur J Surg Oncol. 2008;34:143–8.CrossRefPubMed
4.
go back to reference Adam H, Bygdeson M, de Boniface J. The oncological safety of nipple-sparing mastectomy—a Swedish matched cohort study. Eur J Surg Oncol. 2014;40:1209–15.CrossRefPubMed Adam H, Bygdeson M, de Boniface J. The oncological safety of nipple-sparing mastectomy—a Swedish matched cohort study. Eur J Surg Oncol. 2014;40:1209–15.CrossRefPubMed
5.
go back to reference Verheyden CN. Nipple-sparing total mastectomy of large breasts: the role of tissue expansion. Plast Reconstr Surg. 1998;101:1494–500.CrossRefPubMed Verheyden CN. Nipple-sparing total mastectomy of large breasts: the role of tissue expansion. Plast Reconstr Surg. 1998;101:1494–500.CrossRefPubMed
6.
go back to reference Cense HA, Rutgers EJ, Cardozo ML, Van Lanschot JJ. Nipple-sparing mastectomy in breast cancer: a viable option? Eur J Surg Oncol. 2001;27:521–6.CrossRefPubMed Cense HA, Rutgers EJ, Cardozo ML, Van Lanschot JJ. Nipple-sparing mastectomy in breast cancer: a viable option? Eur J Surg Oncol. 2001;27:521–6.CrossRefPubMed
7.
go back to reference Djohan R, Gage E, Gatherwright J, Pavri S, Firouz J, Bernard S, Yetman R. Patient satisfaction following nipple-sparing mastectomy and immediate breast reconstruction: an 8-year outcome study. Plast Reconstr Surg. 2010;125:818–29.CrossRefPubMed Djohan R, Gage E, Gatherwright J, Pavri S, Firouz J, Bernard S, Yetman R. Patient satisfaction following nipple-sparing mastectomy and immediate breast reconstruction: an 8-year outcome study. Plast Reconstr Surg. 2010;125:818–29.CrossRefPubMed
8.
go back to reference Takayanagi S. Transposition of the malpositioned nipple–areola complex in breast reconstruction with implants. Aesthetic Plast Surg. 2010;34:52–8.CrossRefPubMed Takayanagi S. Transposition of the malpositioned nipple–areola complex in breast reconstruction with implants. Aesthetic Plast Surg. 2010;34:52–8.CrossRefPubMed
9.
go back to reference Choi M, Frey JD, Salibian AA, Karp NS. Nipple–areola complex malposition in nipple-sparing mastectomy: a review of risk factors and corrective techniques from greater than 1000 reconstructions. Plast Reconstr Surg. 2017;140:247e–257e.CrossRefPubMed Choi M, Frey JD, Salibian AA, Karp NS. Nipple–areola complex malposition in nipple-sparing mastectomy: a review of risk factors and corrective techniques from greater than 1000 reconstructions. Plast Reconstr Surg. 2017;140:247e–257e.CrossRefPubMed
10.
go back to reference Wagner JL, Fearmonti R, Hunt KK, et al. Prospective evaluation of the nipple–areola complex sparing mastectomy for risk reduction and for early-stage breast cancer. Ann Surg Oncol. 2012;19:1137–44.CrossRefPubMed Wagner JL, Fearmonti R, Hunt KK, et al. Prospective evaluation of the nipple–areola complex sparing mastectomy for risk reduction and for early-stage breast cancer. Ann Surg Oncol. 2012;19:1137–44.CrossRefPubMed
11.
go back to reference Cordeiro PG, McCarthy CM. A single surgeon’s 12-year experience with tissue expander/implant breast reconstruction: part II. An analysis of long-term complications, aesthetic outcomes, and patient satisfaction. Plast Reconstr Surg. 2006;118:832–9.CrossRefPubMed Cordeiro PG, McCarthy CM. A single surgeon’s 12-year experience with tissue expander/implant breast reconstruction: part II. An analysis of long-term complications, aesthetic outcomes, and patient satisfaction. Plast Reconstr Surg. 2006;118:832–9.CrossRefPubMed
12.
go back to reference Kajikawa A, Ueda K, Tateshita T, Katsuragi Y. Breast reconstruction using tissue expander and TRAM flap with vascular enhancement procedures. J Plast Reconstr Aesthet Surg. 2009;62:1148–53.CrossRefPubMed Kajikawa A, Ueda K, Tateshita T, Katsuragi Y. Breast reconstruction using tissue expander and TRAM flap with vascular enhancement procedures. J Plast Reconstr Aesthet Surg. 2009;62:1148–53.CrossRefPubMed
13.
go back to reference Small K, Kelly KM, Swistel A, et al. Surgical treatment of nipple malposition in nipple-sparing mastectomy device-based reconstruction. Plast Reconstr Surg. 2014;133:1053–62.CrossRefPubMed Small K, Kelly KM, Swistel A, et al. Surgical treatment of nipple malposition in nipple-sparing mastectomy device-based reconstruction. Plast Reconstr Surg. 2014;133:1053–62.CrossRefPubMed
14.
go back to reference Nahabedian MY, Tsangaris TN. Breast reconstruction following subcutaneous mastectomy for cancer: a critical appraisal of the nipple–areola complex. Plast Reconstr Surg. 2006;117:1083–90.CrossRefPubMed Nahabedian MY, Tsangaris TN. Breast reconstruction following subcutaneous mastectomy for cancer: a critical appraisal of the nipple–areola complex. Plast Reconstr Surg. 2006;117:1083–90.CrossRefPubMed
15.
go back to reference Chu C, Carlson G. Techniques and outcomes of nipple sparing mastectomy in the surgical management of breast cancer. Curr Breast Cancer Rep. 2013;5:118–24.CrossRef Chu C, Carlson G. Techniques and outcomes of nipple sparing mastectomy in the surgical management of breast cancer. Curr Breast Cancer Rep. 2013;5:118–24.CrossRef
16.
go back to reference Mori H, Uemura N, Okazaki M, Nakagawa T, Sato T. Nipple malposition after nipple-sparing mastectomy and expander-implant reconstruction. Breast Cancer. 2016;23:740–4.CrossRefPubMed Mori H, Uemura N, Okazaki M, Nakagawa T, Sato T. Nipple malposition after nipple-sparing mastectomy and expander-implant reconstruction. Breast Cancer. 2016;23:740–4.CrossRefPubMed
17.
go back to reference Flessas I, Michalopoulos NV, Zografos GC. Nipple malposition following nipple-sparing mastectomy. How can we prevent it? Breast J. 2016;22:131–2.CrossRefPubMed Flessas I, Michalopoulos NV, Zografos GC. Nipple malposition following nipple-sparing mastectomy. How can we prevent it? Breast J. 2016;22:131–2.CrossRefPubMed
Metadata
Title
Quantitative assessment and risk factors for nipple–areolar complex malposition after nipple-sparing mastectomy
Authors
Takaya Makiguchi
Hideharu Nakamura
Takaaki Fujii
Satoshi Yokoo
Publication date
01-01-2019
Publisher
Springer Japan
Published in
Breast Cancer / Issue 1/2019
Print ISSN: 1340-6868
Electronic ISSN: 1880-4233
DOI
https://doi.org/10.1007/s12282-018-0890-4

Other articles of this Issue 1/2019

Breast Cancer 1/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine